Johnson & Johnson buy Argus
Start price
15:45
/
50%
€200.45
Target price
16.04.27
€232.73
Performance (%)
-0.81%
Price
21:00
€198.82
Summary
This prediction is currently active. The BUY prediction by Argus for Johnson & Johnson is nearly unchanged. This prediction currently runs until 16.04.27. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Johnson & Johnson | -0.81% |
| iShares Core DAX® | 0,44 % |
| iShares Nasdaq 100 | 3,82 % |
| iShares Nikkei 225® | 1,15 % |
| iShares S&P 500 | 2,37 % |
Comments by Argus for this prediction
In the thread Johnson & Johnson diskutieren
Johnson & Johnson (JNJ) had its price target raised by Argus from $240.00 to $275.00. They now have a "buy" rating on the stock.
Ratings data for JNJ provided by MarketBeat